Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16051952 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Tarceva Italian Lung Optimization tRial
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Erlotinib;   Drug: Docetaxel

Study has passed its completion date and status has not been verified in more than two years.